TY - JOUR
T1 - Feasibility of Homeopathic Treatment for Symptom Reduction in an Integrative Oncology Service
AU - Samuels, Noah
AU - Freed, Yakov
AU - Weitzen, Rony
AU - Ben-David, Merav
AU - Maimon, Yair
AU - Eliyahu, Uri
AU - Berger, Raanan
N1 - Publisher Copyright:
© 2017, © The Author(s) 2017.
PY - 2018/6/1
Y1 - 2018/6/1
N2 - Background: Homeopathy has the potential to reduce symptoms related to cancer treatment. The present study examined the feasibility of a homeopathic consultation and treatment program, provided as part of an integrative oncology service. Methods: The electronic medical files of patients undergoing a homeopathic consultation in an integrative oncology service clinic were examined retrospectively. Adherence to the homeopathic treatment regimen and perceived response to the treatment were evaluated. Results: The files of 124 patient (34 males, 90 females) were examined, of which two-thirds reported acquiring and self-administering the homeopathic remedy as prescribed, and nearly three-quarters reporting a beneficial effect. Adherence to the homeopathic treatment regimen was greatest among patients attending a second visit, as opposed to having only telephone/e-mail follow-up (P <.005). An association was found between a perceived beneficial effect of treatment with attending a follow-up visit (P =.04), female gender (P =.02), younger age (P =.048), diagnosis of breast cancer (P =.014), and current radiation treatment (vs chemotherapy; P =.003). Patients reporting chemotherapy-induced peripheral neuropathy were also more likely to report a beneficial effect (P =.004), as were female patients reporting hot flashes (P =.005) and those referred by an oncologist (P =.046). No adverse effects were attributed to the homeopathic treatment. Conclusions: Homeopathy can be successfully incorporated within a supportive care integrative oncology service. In addition to demographic and cancer-related characteristics, as well as symptoms, patients attending a second visit (vs only telephone/e-mail follow-up) were more likely to adhere to and perceive a beneficial effect from the homeopathic regimen.
AB - Background: Homeopathy has the potential to reduce symptoms related to cancer treatment. The present study examined the feasibility of a homeopathic consultation and treatment program, provided as part of an integrative oncology service. Methods: The electronic medical files of patients undergoing a homeopathic consultation in an integrative oncology service clinic were examined retrospectively. Adherence to the homeopathic treatment regimen and perceived response to the treatment were evaluated. Results: The files of 124 patient (34 males, 90 females) were examined, of which two-thirds reported acquiring and self-administering the homeopathic remedy as prescribed, and nearly three-quarters reporting a beneficial effect. Adherence to the homeopathic treatment regimen was greatest among patients attending a second visit, as opposed to having only telephone/e-mail follow-up (P <.005). An association was found between a perceived beneficial effect of treatment with attending a follow-up visit (P =.04), female gender (P =.02), younger age (P =.048), diagnosis of breast cancer (P =.014), and current radiation treatment (vs chemotherapy; P =.003). Patients reporting chemotherapy-induced peripheral neuropathy were also more likely to report a beneficial effect (P =.004), as were female patients reporting hot flashes (P =.005) and those referred by an oncologist (P =.046). No adverse effects were attributed to the homeopathic treatment. Conclusions: Homeopathy can be successfully incorporated within a supportive care integrative oncology service. In addition to demographic and cancer-related characteristics, as well as symptoms, patients attending a second visit (vs only telephone/e-mail follow-up) were more likely to adhere to and perceive a beneficial effect from the homeopathic regimen.
KW - adherence
KW - feasibility
KW - homeopathy
KW - integrative oncology
KW - quality of life
UR - http://www.scopus.com/inward/record.url?scp=85046999350&partnerID=8YFLogxK
U2 - 10.1177/1534735417736133
DO - 10.1177/1534735417736133
M3 - Article
C2 - 29094627
AN - SCOPUS:85046999350
SN - 1534-7354
VL - 17
SP - 486
EP - 492
JO - Integrative Cancer Therapies
JF - Integrative Cancer Therapies
IS - 2
ER -